Measure ID: MIPS 502|Mental Health|2026 Performance Year

Improvement or Maintenance of Functioning for Individuals with a Mental and/or

The percentage of patients aged 18 and older with a mental and/or substance use disorder who demonstrated improvement or maintenance of functioning based on results from the 12-item World Health Organization Disability Assessment Schedule (WHODAS 2.0) or Sheehan Disability Scale (SDS) 30 to 180 days after an index assessment.

Patient-Reported Outcome-based Performance Measure (PRO-PM) – High PriorityMental HealthSubstance UseFunctional Assessment

Last updated: January 15, 2026

⚙️

Measure Specification

Denominator (Eligible Population)

Patients aged 18 years and older as of the date of the index encounter
ANDDiagnosis for any mental, behavioral, or substance use disorder on date of index encounter
ANDPatient encounter during the denominator identification period
ANDIndex assessment completed using the 12-item WHODAS 2.0 or SDS during the denominator identification period: M1340

Denominator Exclusions2

M1473Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
M1342Patients who died during the performance period: M1342

Numerator

Patients who demonstrated improvement or maintenance of functioning, as demonstrated by results of follow-up assessment using the 12-item WHODAS 2.0 or Sheehan Disability Scale 30 to 180 days after the index assessment during the performance period.

Submission Codes (QDCs)

✓ Performance Met
M1339Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
✗ Performance Not Met
M1338Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
M1341Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period

Denominator Exceptions

None — this measure has no denominator exceptions.

🧮MIPS Score Simulator

Estimate only — actual CMS scoring may vary based on reporting method, data completeness, and annual rule updates.

%Benchmarks vary by collection type
💡 Tip: Enter your performance rate to compare MIPS points across all collection types. The same rate can score differently depending on how you submit.
VBCA Insights

💡Why This Measure Matters

Patients with mental health or substance use disorders should show improvement or maintenance of functioning over time, measured by a standardized disability scale (WHODAS 2.0 or SDS). This outcome measure asks: are your patients actually getting better at managing their daily lives—work, relationships, self-care? Give the baseline assessment at the first visit, repeat it 30 to 180 days later, and adjust treatment if functioning is worsening. Functional improvement is the real goal of mental health and addiction treatment.

📖Clinical Rationale

Mental and substance use disorders are among the 25 leading causes of years lived with disability and contribute significantly to the global burden of disease. Specifically, 19% of U.S. adults (46.6 million individuals aged 18 and older) have a mental illness and 7.6% (18.7 million individuals aged 18 and older) have a substance use disorder. Mental and substance use disorders often co-occur, with about 8.

5 million adults aged 18 and older in the U.S. having both conditions. Individuals with mental and/or substance use disorders are more likely to report severe impairment in functioning compared to those with chronic medical conditions. In fact, the level and pattern of functional impairment is described as the best indicator of service needs, treatment outcomes, and quality care, with greater level of functional impairment being a risk factor for poor prognosis for both mental and substance use disorders as well other medical conditions.

Improvement or maintaining functioning is strongly predictive of a positive outcome. Improvement or maintaining functioning is strongly predictive of a positive outcome.

📝Clinical Recommendations

WHO Disability Assessment Scale 2.0 (WHODAS 2.0) (Ustun et al., 2010) assesses change-over-time in functioning for all individuals with mental health and/or substance use disorders. The domains covered in the tool are communication and understanding, mobility, self-care, social functioning, life activities (work and home), and participation in society.

Response options include: (0) None, (1) Mild, (2) Moderate, (3) Severe, and (4) Extreme or Cannot Do. A 12-item and 36-item version of the WHODAS 2.0 are available. Summed scores on the 12-item and 36-item WHODAS 2.0 are converted to a summary scale from 0 to 100 (where 0 = no disability; 100 = full disability). There is no recommended cutoff score.

A higher score on the WHODAS 2.0 equates to a lower level of functioning. Available at: https://www.who.int/standards/classifications/international-classification-of-functioning-disability-and-health/who- disability-assessment-schedule. Sheehan Disability Scale (SDS) (Sheehan et al., 2008) assesses change-over-time in functioning for individuals with mental health and/or substance use disorders.

The domains covered in the tool are work/school, social life/leisure activities, and family life/home responsibilities. Response options include: (0) Not at all, (1-3) Mildly, (4-6) Moderately, (7-9) Markedly, and (10) Extremely, regarding how current symptoms have disrupted activities in each of the domains covered by the assessment. The 3 items are summed into a single dimensional measure of global functioning from 0 to 30 (where 0 = unimpaired and 30 = highly impaired).

There is no recommended cutoff score. A higher score on the SDS equates to a lower level of functioning. Available at: https://harmresearch.org/about-us/david-v-sheehan-md- mba/sheehan-scales-and-structured-diagnostic-interviews/sheehan-disability-scale-sds.

📋Implementation Notes

This measure contains one strata defined by a single submission criteria. This measure produces a single performance rate. For the purposes of MIPS implementation, this patient-periodic measure is submitted a minimum of once per patient per timeframe specified by the measure during the performance period. The most advantageous quality data code will be used if the measure is submitted more than once.

Report this measure through VBCA

Our QCDR handles measure selection, data validation, and submission—so you can focus on clinical performance.

Learn About Our QCDR →
© 2026 APA and NCQA. All rights reserved. © 2026 APA and NCQA, all rights reserved.